Camber Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Sell |
450,000
-550,000
| -55% | -$6.07M | 0.47% | 21 |
|
|
2025
Q1 | $8.93M | Hold |
1,000,000
| – | – | 0.32% | 23 |
|
|
2024
Q4 | $9.41M | Hold |
1,000,000
| – | – | 0.22% | 34 |
|
|
2024
Q3 | $8.06M | Hold |
1,000,000
| – | – | 0.26% | 29 |
|
|
2024
Q2 | $8.48M | Hold |
1,000,000
| – | – | 0.23% | 32 |
|
|
2024
Q1 | $8.97M | Buy |
+1,000,000
| New | +$8.97M | 0.22% | 31 |
|
|
2022
Q1 | – | Sell |
-500,000
| Closed | -$5.53M | – | 43 |
|
|
2021
Q4 | $5.53M | Sell |
500,000
-2,000,000
| -80% | -$22.1M | 0.19% | 32 |
|
|
2021
Q3 | $18.5M | Buy |
+2,500,000
| New | +$18.5M | 0.57% | 32 |
|